Search Results - "Oura, Kyoko"

Correction: Morishita et al. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers 2021, 13 , 514.

Authors: Morishita, Asahiro Oura, Kyoko Tadokoro, Tomoko et al.

Source: Cancers. Jan2026, Vol. 18 Issue 2, p232. 3p.

Genetic Polymorphisms of ALDH2 and ADH1B in Alcohol-Induced Liver Injury: Molecular Mechanisms of Inflammation and Disease Progression in East Asian Populations.

Authors: Tadokoro, Tomoko Oura, Kyoko Nakahara, Mai et al.

Source: International Journal of Molecular Sciences. Sep2025, Vol. 26 Issue 17, p8328. 14p.

Advances in the Therapeutic Landscape of Hepatocellular Carcinoma: Current Strategies and Future Perspectives.

Authors: Morishita, Asahiro Oura, Kyoko Tai, Hiroki et al.

Source: Cancers. Feb2026, Vol. 18 Issue 4, p609. 29p.

Fibroblast growth factor receptor 2 alterations in intrahepatic cholangiocarcinoma: Prevalence and clinical implications in Asian populations.

Authors: Oura, Kyoko Morishita, Asahiro Kobara, Hideki

Source: Hepatology Research. Jul2025, Vol. 55 Issue 7, p963-965. 3p.

Chronic Liver Disease Associated Cholangiocarcinoma: Genomic Insights and Precision Therapeutic Strategies.

Authors: Oura, Kyoko Morishita, Asahiro Nakahara, Mai et al.

Source: Cancers. Sep2025, Vol. 17 Issue 18, p3052. 28p.

Efficacy and outcome of molecular targeted therapies in elderly patients with hepatocellular carcinoma: Relative dose intensity associated with overall survival.

Authors: Oura, Kyoko Morishita, Asahiro Takuma, Kei et al.

Source: Cancer Medicine. Dec2023, Vol. 12 Issue 24, p22023-22037. 15p.

Relationship between Accurate Diagnosis of Sarcopenia and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab Combination Therapy.

Authors: Oura, Kyoko Morishita, Asahiro Manabe, Takushi et al.

Source: Cancers. Jun2023, Vol. 15 Issue 12, p3243. 15p.

Prognostic Value of Skeletal Muscle Loss in Patients with Hepatocellular Carcinoma Treated with Hepatic Arterial Infusion Chemotherapy.

Authors: Oura, Kyoko Morishita, Asahiro Tani, Joji et al.

Source: Cancers. Mar2023, Vol. 15 Issue 6, p1834. 15p.

The Involvement of Apoptosis Inhibitor of Macrophage in the Disease Severity of Primary Biliary Cholangitis.

Authors: Himoto, Takashi Mori, Erika Tanimoto, Manami et al.

Source: Journal of Clinical Medicine. Feb2026, Vol. 15 Issue 3, p1169. 11p.

Immune Microenvironment and the Effect of Vascular Endothelial Growth Factor Inhibition in Hepatocellular Carcinoma.

Authors: Oura, Kyoko Morishita, Asahiro Tadokoro, Tomoko et al.

Source: International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 24, p13590. 18p.

Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration.

Authors: Fujita, Koji Takuma, Kei Oura, Kyoko et al.

Source: CTS: Clinical & Translational Science. Mar2025, Vol. 18 Issue 3, p1-12. 12p.

Galectins and Liver Diseases.

Authors: Mimura, Shima Morishita, Asahiro Oura, Kyoko et al.

Source: International Journal of Molecular Sciences. Jan2025, Vol. 26 Issue 2, p790. 19p.

Serum microRNA-125a-5p as a potential biomarker of HCV-associated hepatocellular carcinoma.

Authors: Oura, Kyoko Fujita, Koji Morishita, Asahiro et al.

Source: Oncology Letters. Jul2019, Vol. 18 Issue 1, p882-890. 9p.

Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets.

Authors: Mimura, Shima Morishita, Asahiro Oura, Kyoko et al.

Source: Journal of Clinical Medicine. Dec2025, Vol. 14 Issue 23, p8503. 22p.

A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 Index.

Authors: Tadokoro, Tomoko Kawanaka, Miwa Takahashi, Hirokazu et al.

Source: Diagnostics (2075-4418). Apr2025, Vol. 15 Issue 8, p1023. 13p.

Recent advances in systemic therapies for unresectable hepatocellular carcinoma and their impact on clinical outcomes.

Authors: Oura, Kyoko¹ (AUTHOR) oura.kyoko@kagawa-u.ac.jp

Source: Hepatology Research. Feb2025, Vol. 55 Issue 2, p163-165. 3p.

MicroRNAs and Nonalcoholic Steatohepatitis: A Review.

Authors: Morishita, Asahiro Oura, Kyoko Tadokoro, Tomoko et al.

Source: International Journal of Molecular Sciences. Oct2023, Vol. 24 Issue 19, p14482. 15p.

Cisplatin in Liver Cancer Therapy.

Authors: Hamaya, Sae Oura, Kyoko Morishita, Asahiro et al.

Source: International Journal of Molecular Sciences. Jul2023, Vol. 24 Issue 13, p10858. 25p.

Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C.

Authors: Fujita, Koji Oura, Kyoko Yoneyama, Hirohito et al.

Source: Hepatology Research. Jul2019, Vol. 49 Issue 7, p731-742. 12p.

Alcohol-related cancer morbidity and mortality are stratified using modified albumin platelet product.

Authors: Fujita, Koji Morishita, Asahiro Oura, Kyoko et al.

Source: Scientific Reports. 1/10/2024, Vol. 14 Issue 1, p1-8. 8p.